Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Federico

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2008
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized studyV Pavone, U Ricardi, S Luminari, et al.
Journal of Pediatric Hematology/Oncology|March 18, 2014
Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastomaSara M Federico, Heather B Allewelt, Sheri L Spunt, et al.
Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Cancer|June 21, 2025
Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitorsJessica Gartrell, Daniel A Mulrooney, Chia-Wei Hsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)M Ghielmini, U Vitolo, E Kimby, et al.
Haematologica|September 5, 2001
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphomaS Sacchi, M Federico, U Vitolo, et al.
Cancers|June 12, 2026
Longitudinal Functional Outcomes Among Survivors of Childhood Lower Extremity OsteosarcomaAmy M Berkman, Matthew D Wogksch, Robyn E Partin, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2008
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized studyV Pavone, U Ricardi, S Luminari, et al.
Journal of Pediatric Hematology/Oncology|March 18, 2014
Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastomaSara M Federico, Heather B Allewelt, Sheri L Spunt, et al.
Blood|May 16, 1998
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's diseaseP G Gobbi, C Pieresca, M L Ghirardelli, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Cancer|June 21, 2025
Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitorsJessica Gartrell, Daniel A Mulrooney, Chia-Wei Hsu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)M Ghielmini, U Vitolo, E Kimby, et al.
Haematologica|September 5, 2001
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphomaS Sacchi, M Federico, U Vitolo, et al.
Cancers|June 12, 2026
Longitudinal Functional Outcomes Among Survivors of Childhood Lower Extremity OsteosarcomaAmy M Berkman, Matthew D Wogksch, Robyn E Partin, et al.
Pageof 26